Atopic dermatitis (AD) is a chronic, relapsing skin inflammation affecting over 17% of adults and 22% of children every year. In the case of moderate-to-severe AD, systemic treatments such as systemic corticosteroids, phototherapy, and immunosuppressants are essential. However, the adverse effects of these systemic treatments necessitate safe and effective long-term therapy for refractory AD. In addition, biological therapies for AD are associated with the onset of paradoxical adverse effects, which is a challenging issue. Therefore, biological therapies must undergo a careful clinical and immunological evaluation.
To know more about the diagnosis and management of atopic dermatitis, join us for an exclusive ClinShots session with eminent dermatologist Dr. Prof. Jayakar Thomas on “ Game Changers in Atopic Dermatitis ” on 6 th December, 6:00 PM IST onwards. Session Highlights:…
